Bioanalytical Assay Development for PaVe-GT
- Solicitation Status Awarded
- Date Awarded
- Research Category Research & Development Services & Subcontracts
- Solicitation Number S23-036
- NCI OA Contract Number 75N91019D00024 – NCI-FFRDC
Description
The goal is the development and validation of three types of immunogenicity assays: Enzymatic Immunoassays (EIA, commonly referred to as Anti-Drug Antibody [ADA] assays), ELISpot assays, and Neutralizing Antibody (NAb) assays that will require the development and validation of the assays and the testing of clinical samples, collected before and after treatment with an AAV-GOI product.
Proposal Instructions
In order to receive the full solicitation package, please contact Shaneeka Owens at shaneeka.owens-bearden@nih.gov.
Questions regarding this solicitation are due no later than 4:00PM ET Thursday March 16, 2023.
Offers are due no later than 4:00PM ET Thursday April 20, 2023.
| Modified By | Date Modified Sort ascending | Comment |
|---|---|---|
| Shaneeka Owens | PLEASE SUBMIT OFFERS TO MS. SHANEEKA OWENS AT SHANEEKA.OWENS-BEARDEN@NIH.GOV
This is an Amendment #1 to the original Solicitation S23-036 closed two weeks ago. This Amendment #1 provided questions and answers and extended the Proposal due date to April 20, 2023. |